NCT02782949View on ClinicalTrials.gov

Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 4, 2017

Primary Completion Date

October 6, 2022

Study Completion Date

April 1, 2026

Conditions
Chronic Atrophic GastritisGastric Carcinoma
Interventions
DRUG

Curcumin

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Placebo Administration

Given PO

OTHER

Quality-of-Life Assessment

Ancillary studies

Trial Locations (2)

41101

Hospital Regional de Occidente, Santa Rosa de Copán

00936

University of Puerto Rico, San Juan

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH